Improving human health through Biomedical innovation and discovery.

Colon Cancer Related Human Specimens

1929 Colon Cancer Patients

Note: The majority of patients have donated multiple samples.

Biorepository icon: frozen samples

Frozen samples: 924

Biorepository icon: serum samples

Serum: 188

Biorepository icon: FFPE samples

FFPE: 528

Biorepository icon: DNA samples

DNA: 959

Biorepository icon: RNA samples

RNA: 88

Additional Information

  • Comprehensive, de-identified, covariate data such as age, gender, diet, body mass index (BMI), and race in addition to complete diagnostic and treatment history
  • Access to additional samples and longitudinal data are available for some custom programs.

Speak to our experts

Global Biorepository

Inventory by disease

NEW COVID-19

On the REPROCELL blog

Latest in Drug Discovery

New Therapeutic Targets: The Role of IL17-Related Genes in Precision Medicine

New Therapeutic Targets: The Role of IL17-Related Genes in Precision Medicine

Discover how IL-17 related genes could revolutionize psoriasis treatment, offering new therapeutic targets and paving the way for precision medicine advancements.

09 June 2025

Balancing Efficacy and Cognitive Health In Bladder Assays

Balancing Efficacy and Cognitive Health In Bladder Assays

New approaches in OAB treatment focus on balancing efficacy and cognitive health, using alternatives to anticholinergics and personalized medicine to improve patient outcomes.

23 May 2025

Key Strategies Central Labs Use to Fast-Track Time to Market

Key Strategies Central Labs Use to Fast-Track Time to Market

Learn how central labs use automation, outsourcing, and AI to accelerate drug development, reduce costs, and improve clinical trial accuracy and efficiency.

21 May 2025

More in Drug Discovery